Paul Savage
Paul Savage
General Surgery Resident, University of Toronto
Verified email at mail.utoronto.ca
Title
Cited by
Cited by
Year
YAP-induced resistance of cancer cells to antitubulin drugs is modulated by a Hippo-independent pathway
Y Zhao, P Khanal, P Savage, YM She, TD Cyr, X Yang
Cancer research 74 (16), 4493-4503, 2014
692014
ERRα mediates metabolic adaptations driving lapatinib resistance in breast cancer
G Deblois, HW Smith, IS Tam, SP Gravel, M Caron, P Savage, DP Labbé, ...
Nature communications 7 (1), 1-14, 2016
512016
The receptor tyrosine kinase AXL is required at multiple steps of the metastatic cascade during HER2-positive breast cancer progression
MA Goyette, S Duhamel, L Aubert, A Pelletier, P Savage, MP Thibault, ...
Cell reports 23 (5), 1476-1490, 2018
452018
Lyn modulates Claudin-2 expression and is a therapeutic target for breast cancer liver metastasis
S Tabariès, MG Annis, BE Hsu, CE Tam, P Savage, M Park, PM Siegel
Oncotarget 6 (11), 9476, 2015
402015
Sumoylation of Krüppel-like factor 4 inhibits pluripotency induction but promotes adipocyte differentiation
S Tahmasebi, M Ghorbani, P Savage, K Yan, G Gocevski, L Xiao, L You, ...
Journal of Biological Chemistry 288 (18), 12791-12804, 2013
352013
A targetable EGFR-dependent tumor-initiating program in breast cancer
P Savage, A Blanchet-Cohen, T Revil, D Badescu, SMI Saleh, YC Wang, ...
Cell reports 21 (5), 1140-1149, 2017
332017
The SUMO conjugating enzyme Ubc9 is required for inducing and maintaining stem cell pluripotency
S Tahmasebi, M Ghorbani, P Savage, G Gocevski, XJ Yang
Stem cells 32 (4), 1012-1020, 2014
262014
Dual MAPK inhibition is an effective therapeutic strategy for a subset of class II BRAF mutant melanomas
M Dankner, M Lajoie, D Moldoveanu, TT Nguyen, P Savage, S Rajkumar, ...
Clinical Cancer Research 24 (24), 6483-6494, 2018
152018
Targeting EZH2 reactivates a breast cancer subtype-specific anti-metastatic transcriptional program
A Hirukawa, HW Smith, D Zuo, CR Dufour, P Savage, N Bertos, ...
Nature communications 9 (1), 1-15, 2018
122018
Canadian MD-Ph. D. Programs Produce Impactful Physician-Scientists: The McGill Experience
TE Zhou, PA Savage, MJ Eisenberg
Neurology 2, 22.2, 2016
92016
Motif-based evidence that a plastid translocon component acts like a rhomboid protease substrate in yeast mitochondria
J Powles, P Savage, E Wu, K Karakasis, K Ko
Botany 89 (7), 499-511, 2011
62011
DZ-2384 has a superior preclinical profile to taxanes for the treatment of triple-negative breast cancer and is synergistic with anti-CTLA-4 immunotherapy
C Bernier, A Soliman, M Gravel, M Dankner, P Savage, K Petrecca, ...
Anti-cancer drugs 29 (8), 774, 2018
52018
Activation of the pattern recognition receptor NOD1 augments colon cancer metastasis
HY Jiang, S Najmeh, G Martel, E MacFadden-Murphy, R Farias, P Savage, ...
Protein & cell 11 (3), 187-201, 2020
42020
The effect of the American Joint Committee on Cancer eighth edition on breast cancer staging and prognostication
P Savage, N Yu, S Dumitra, S Meterissian
European Journal of Surgical Oncology 45 (10), 1817-1820, 2019
42019
Epigenetic switch–induced viral mimicry evasion in chemotherapy-resistant breast cancer
G Deblois, SAM Tonekaboni, G Grillo, C Martinez, YI Kao, F Tai, I Ettayebi, ...
Cancer discovery 10 (9), 1312-1329, 2020
32020
An ErbB2/c-Src axis links bioenergetics with PRC2 translation to drive epigenetic reprogramming and mammary tumorigenesis
HW Smith, A Hirukawa, V Sanguin-Gendreau, I Nandi, CR Dufour, D Zuo, ...
Nature communications 10 (1), 1-19, 2019
32019
Chemogenomic profiling of breast cancer patient-derived xenografts reveals targetable vulnerabilities for difficult-to-treat tumors
P Savage, A Pacis, H Kuasne, L Liu, D Lai, A Wan, M Dankner, ...
Communications biology 3 (1), 1-15, 2020
22020
Incidence and predictors of postoperative ileus after loop ileostomy closure: a systematic review and meta-analysis
R Garfinkle, P Savage, M Boutros, T Landry, P Reynier, N Morin, ...
Surgical endoscopy, 1-14, 2019
22019
65. INVASIVE HISTOPATHOLOGY DRIVES POOR OUTCOMES IN SURGICALLY RESECTED BRAIN METASTASES
M Dankner, M Caron, T Al-Saadi, WQ Yu, V Ouellet, P Uyen Le, ...
Neuro-Oncology Advances 2 (Supplement_2), ii13-ii14, 2020
2020
TMOD-41. ORTHOTOPIC PATIENT-DERIVED XENOGRAFT MODELS OF BRAIN METASTASIS: PLATFORMS FOR PRECISION ONCOLOGY AND UNDERSTANDING TUMOR BIOLOGY
M Dankner, P Savage, A Rose, M Lajoie, R Diaz, M Park, I Watson, ...
Neuro-oncology 21 (Supplement_6), 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–20